Warning: The NCBI web site requires JavaScript to function. more...
TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
Arthritis Res Ther. 2006;8(5):R146.
Related citations
Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes.
Jin L, Nakao A, Nakayama M, Yamaguchi N, Kojima Y, Nakano N, Tsuboi R, Okumura K, Yagita H, Ogawa H.
J Invest Dermatol. 2004 May;122(5):1175-9.
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T.
J Biol Chem. 2003 Aug 22;278(34):32317-23. Epub 2003 Jun 6.
Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.
J Biol Chem. 2004 Sep 24;279(39):40267-75. Epub 2004 May 18.
Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ.
J Bone Miner Res. 2009 Aug;24(8):1434-49.
Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways.
Tsubaki M, Kato C, Manno M, Ogaki M, Satou T, Itoh T, Kusunoki T, Tanimori Y, Fujiwara K, Matsuoka H, Nishida S.
Mol Cell Biochem. 2007 Oct;304(1-2):53-60. Epub 2007 Jun 5.
Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT.
J Bone Miner Res. 2002 Jan;17(1):101-10.
Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
Clin Exp Immunol. 2006 Dec;146(3):540-9.
Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J.
J Bone Miner Res. 2003 Nov;18(11):2060-8.
Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis.
Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K.
J Biol Chem. 2004 Apr 2;279(14):13555-63. Epub 2004 Jan 16.
Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.
Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG.
J Biol Chem. 2002 Sep 6;277(36):33361-8. Epub 2002 Jun 25. Erratum in: J Biol Chem. 2003 May 2;278(18):16452.
Alpha1-adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor kappaB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells.
Nishiura T, Abe K.
Arch Oral Biol. 2007 Aug;52(8):778-85. Epub 2007 Feb 15.
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME.
J Biol Chem. 2005 Feb 4;280(5):3483-92. Epub 2004 Dec 16.
Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts.
Ebihara N, Nakayama M, Tokura T, Ushio H, Murakami A.
Exp Eye Res. 2009 Aug;89(2):256-62. Epub 2009 Apr 1.
Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro.
Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M.
J Cell Physiol. 2000 Aug;184(2):197-206.
A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts.
Ikawa Y, Yonekawa T, Ohkuni Y, Kuribayashi M, Fukino K, Ueno K.
J Toxicol Sci. 2007 Dec;32(5):555-64.
Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2.
Viñals F, López-Rovira T, Rosa JL, Ventura F.
FEBS Lett. 2002 Jan 2;510(1-2):99-104.
Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
J Endocrinol. 2008 Mar;196(3):601-13.
Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes.
Tiller G, Fischer-Posovszky P, Laumen H, Finck A, Skurk T, Keuper M, Brinkmann U, Wabitsch M, Link D, Hauner H.
Endocrinology. 2009 Dec;150(12):5373-83. Epub 2009 Nov 3.
TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A.
Biochem Biophys Res Commun. 2004 May 28;318(2):422-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on